07:20:43 EDT Thu 16 Jul 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for C:PRN from 2025-07-17 to 2026-07-16 - 45 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2026-07-15 07:45C:PRNPROFOUND MEDICAL CORP.9.98News ReleaseProfound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026
2026-05-15 11:20C:PRNProfound Medical Corp (2)9.82News ReleaseProfound, Telix form partnership on prostate imaging
2026-05-14 07:00C:PRNPROFOUND MEDICAL CORP.9.72News ReleaseProfound to Showcase TULSA-PRO(TM), the TULSA Procedure(TM) and the Future of iMRI at AUA2026
2026-05-13 20:41C:PRNPROFOUND MEDICAL CORP.9.72News ReleaseProfound Medical Annual General and Special Meeting of Shareholders Voting Results
2026-05-07 17:37C:PRNProfound Medical Corp (2)9.75SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-05-07 17:37C:PRNProfound Medical Corp (2)9.75SEDAR Interim MD & ASEDAR Interim MD & A
2026-05-07 16:05C:PRNPROFOUND MEDICAL CORP.9.89News ReleaseProfound Medical Reports Strong First Quarter 2026 Financial Results
2026-04-16 19:05C:PRNProfound Medical Corp (2)9.12News ReleaseProfound to release Q1 results, host call May 7
2026-04-14 07:30C:PRNPROFOUND MEDICAL CORP.8.51News ReleaseProfound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference
2026-04-01 08:15C:PRNPROFOUND MEDICAL CORP.8.90News ReleaseIncision-Free, MRI-Guided Prostate Treatment with Profound's TULSA-PRO(TM) to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting
2026-03-27 15:15C:PRNProfound Medical Corp (2)8.57News ReleaseProfound talks up Tulsa procedure milestone in Texas
2026-03-13 10:30C:PRNPROFOUND MEDICAL CORP.7.59News ReleaseCAPTAIN Trial Comparing Profound's MRI-Guided TULSA Procedure(TM) to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence
2026-03-10 01:07C:PRNProfound Medical Corp (2)7.07News ReleaseProfound to discuss Captain trial results March 13
2026-03-05 18:03C:PRNProfound Medical Corp (2)10.00SEDAR Annual ReportSEDAR Annual Report
2026-03-05 17:40C:PRNProfound Medical Corp (2)10.00SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2026-03-05 17:40C:PRNProfound Medical Corp (2)10.00SEDAR MD & ASEDAR MD & A
2026-03-05 16:05C:PRNPROFOUND MEDICAL CORP.10.14News ReleaseProfound Medical Reports Fourth Quarter and Full Year 2025 Financial Results
2026-02-12 22:18C:PRNProfound Medical Corp (2)8.50News ReleaseProfound Medical to release 2025 results March 5
2026-02-12 08:30C:PRNPROFOUND MEDICAL CORP.8.64News ReleaseProfound Medical Honored with INOVAIT's 2025-2026 Mount Logan Award Recognizing the TULSA Procedure(TM) for Prostate Disease
2026-02-05 18:29C:PRNProfound Medical Corp (2)8.75News ReleaseProfound sees Polish hospital complete 500th procedure
2026-01-27 16:30C:PRNPROFOUND MEDICAL CORP.10.45News ReleaseProfound Medical Announces Upcoming Investor Events
2026-01-15 17:19C:PRNProfound Medical Corp (2)11.53News ReleaseProfound Medical has success at Mount Sinai Hospital
2026-01-12 18:44C:PRNProfound Medical Corp (2)12.11News ReleaseProfound's Dec. 31 Tulsa-Pro installed base at 78
2026-01-06 17:09C:PRNProfound Medical Corp (2)10.67News ReleaseProfound sees first Johns Hopkins Tulsa case
2025-12-30 17:54C:PRNProfound Medical Corp (2)9.91News ReleaseProfound Medical closes $6.45-million (U.S.) financing
2025-12-24 20:35C:PRNProfound Medical Corp (2)10.25News ReleaseProfound increases private placement to $6.45M (U.S.)
2025-12-23 16:19C:PRNProfound Medical Corp (2)10.04News ReleaseProfound closes $36-million offering
2025-12-19 16:23C:PRNProfound Medical Corp (2)10.46News ReleaseProfound arranges $40-million financing
2025-11-28 16:28C:PRNProfound Medical Corp (2)9.08News ReleaseProfound Medical to roll out Tulsa-AI BPH module
2025-11-18 16:15C:PRNPROFOUND MEDICAL CORP.8.58News ReleaseProfound Medical Celebrates The Hong Center's 200th Independent TULSA Procedure for Prostate Disease
2025-11-13 16:52C:PRNProfound Medical Corp (2)9.04SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-11-13 16:52C:PRNProfound Medical Corp (2)9.04SEDAR Interim MD & ASEDAR Interim MD & A
2025-11-13 16:05C:PRNPROFOUND MEDICAL CORP.9.05News ReleaseProfound Medical Reports Strong Third Quarter 2025 Financial Results
2025-11-12 18:52C:PRNProfound Medical Corp (2)9.05News ReleaseProfound signs Australia, NZ distribution deal
2025-11-11 18:03C:PRNProfound Medical Corp (2)9.05News ReleaseProfound signs exclusive Saudi Arabia distribution deal
2025-11-10 16:30C:PRNPROFOUND MEDICAL CORP.8.37News ReleaseProfound Medical Regains Exclusive Distribution Rights for TULSA-PRO(TM) in Canada from Knight
2025-10-16 17:44C:PRNProfound Medical Corp (2)7.74News ReleaseProfound Medical upbeat about Busch Center results
2025-10-14 08:30C:PRNPROFOUND MEDICAL CORP.8.00News ReleaseProfound Medical to Participate in the Stifel 2025 Healthcare Conference
2025-10-07 17:20C:PRNProfound Medical Corp (2)8.79News ReleaseProfound estimates Q3 revenue of $5.2-million (U.S.)
2025-09-23 17:45C:PRNProfound Medical Corp (2)7.00News ReleaseProfound Medical talks Tulsa use by Texas Prostate
2025-08-28 08:00C:PRNPROFOUND MEDICAL CORP.6.22News ReleaseProfound Medical to Participate in Lake Street's 9th Annual Best Ideas Growth Conference
2025-08-14 16:47C:PRNProfound Medical Corp (2)7.54SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-08-14 16:47C:PRNProfound Medical Corp (2)7.54SEDAR Interim MD & ASEDAR Interim MD & A
2025-08-14 16:05C:PRNPROFOUND MEDICAL CORP.7.57News ReleaseProfound Medical Announces Second Quarter 2025 Financial Results
2025-07-24 22:47C:PRNProfound Medical Corp (2)8.04News ReleaseProfound Medical to release Q2 results Aug. 14